Literature DB >> 23020783

Clinicopathological analysis of mediastinal large B-cell lymphoma and classical Hodgkin lymphoma of the mediastinum.

Wataru Yamamoto1, Naoya Nakamura, Naoto Tomita, Yoshimi Ishii, Hirotaka Takasaki, Chizuko Hashimoto, Shigeki Motomura, Etsuko Yamazaki, Rika Ohshima, Ayumi Numata, Yoshiaki Ishigatsubo, Rika Sakai.   

Abstract

Primary mediastinal (thymic) large B-cell lymphoma (PMLBCL) and nodular sclerosing classical Hodgkin lymphoma (NSCHL) are the major histological types of lymphoma affecting the mediastinum. We reviewed 27 patients with PMLBCL and 14 patients with NSCHL. A poor performance status, high serum lactate dehydrogenase level and strong positivity for PAX5 were all significantly more common in patients with PMLBCL than in those with NSCHL. Severe fibrosis was frequent in NSCHL, but not in PMLBCL. PDL1 was expressed by 11/25 PMLBCLs (44.0%) vs. 1/9 NSCHLs (11.1%). Expression of BCL6 was significantly more frequent in PDL1-positive PMLBCL than in PDL1-negative PMLBCL, but there were no clinical differences between these two groups. Two patients with PMLBCL with a poor prognosis had CD20(-), CD79a(+), CD15(-), and CD30(-), possibly representing a subtype of mediastinal gray zone lymphoma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23020783     DOI: 10.3109/10428194.2012.733881

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  4 in total

1.  Prognostic significance of pleural or pericardial effusion and the implication of optimal treatment in primary mediastinal large B-cell lymphoma: a multicenter retrospective study in Japan.

Authors:  Tomohiro Aoki; Koji Izutsu; Ritsuro Suzuki; Chiaki Nakaseko; Hiroshi Arima; Kazuyuki Shimada; Akihiro Tomita; Makoto Sasaki; Jun Takizawa; Kinuko Mitani; Tadahiko Igarashi; Yoshinobu Maeda; Noriko Fukuhara; Fumihiro Ishida; Nozomi Niitsu; Ken Ohmachi; Hirotaka Takasaki; Naoya Nakamura; Tomohiro Kinoshita; Shigeo Nakamura; Michinori Ogura
Journal:  Haematologica       Date:  2014-09-12       Impact factor: 9.941

2.  CD20 Over-Expression in Hodgkin-Reed-Sternberg Cells of Classical Hodgkin Lymphoma: the Neglected Quest.

Authors:  Daniel Benharroch; Karen Nalbandyan; Irina Lazarev
Journal:  J Cancer       Date:  2015-09-15       Impact factor: 4.207

Review 3.  Primary Mediastinal B-Cell Lymphoma: Novel Precision Therapies and Future Directions.

Authors:  Huan Chen; Tao Pan; Yizi He; Ruolan Zeng; Yajun Li; Liming Yi; Hui Zang; Siwei Chen; Qintong Duan; Ling Xiao; Hui Zhou
Journal:  Front Oncol       Date:  2021-03-22       Impact factor: 6.244

4.  Immune regulatory effects of panobinostat in patients with Hodgkin lymphoma through modulation of serum cytokine levels and T-cell PD1 expression.

Authors:  Y Oki; D Buglio; J Zhang; Y Ying; S Zhou; A Sureda; D Ben-Yehuda; P L Zinzani; H M Prince; S J Harrison; M Kirschbaum; P B Johnston; A Shen; B von Tresckow; A Younes
Journal:  Blood Cancer J       Date:  2014-08-08       Impact factor: 11.037

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.